Dr. Venu Gopal Bathini, MD

Dr. Bathini practices at Charles River Medical Associates - Framingham (Union Ave) in Framingham, Massachusetts.

Dr. Bathini's NPI, 1578658563, was assigned on October 4, 2006. Dr. Bathini holds Massachusetts license 208195.

Dr. Bathini's primary practice is Charles River Medical Associates - Framingham (Union Ave), at 571 Union Ave Ste 102, Framingham, MA 01702. The practice phone is (508) 848-2164.

Dr. Bathini's primary practice is Charles River Medical Associates - Framingham (Union Ave) in Framingham, Massachusetts. Dr. Bathini is also affiliated with Brigham and Women's Hospital. The medical group on file is Charles River Medical Associates. Dmand AI also links Dr. Bathini to 1 more breast imaging center, 1 hospice and 1 ambulatory surgery center, each named with a free account. Dr. Bathini's employer is on file too: an imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bathini practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bathini's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bathini is licensed in Massachusetts.

CMS data shows 113,566 Medicare services from Dr. Bathini across 27 procedure codes in 2024, for 461 Medicare patients. Medicare paid $456,335 for them. Every service was in an office.

CMS counts 461 Medicare patients who saw Dr. Bathini in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bathini's median patient age at 68, with 53% women.

In 2024, Dr. Bathini wrote 637 Medicare Part D claims for 136 patients. 71% of them were for generic drugs. CMS names the drug for 398 of them, across 16 drugs with 11 or more claims each, at $500,778 in total drug cost. In 2023, CMS named 303 claims across 15 drugs.

Dr. Bathini accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bathini as offering telehealth.

Dmand AI links 12 papers to Dr. Bathini, published from 2016 to 2021. 2018 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, DNA Mutational Analysis and High-Throughput Nucleotide Sequencing. Dr. Bathini's most frequent co-authors are Carol M. Mathew, MD, Lacey J. McIntosh, DO, MPH and Zeina Adli Ahmad Al-Mansour, MD.

CMS Open Payments shows 85 general payments to Dr. Bathini from 37 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 69% of the total. US Oncology Corporate, Inc. paid the most, $1,637. It also lists 2 research payments totaling $2,551 from 2016 to 2017.